Fundraising Fox

Aakha

<UNKNOWN> · Delaware corporation · 1 known investors

aakha.bio ↗

Aakha Bio develops multi-specific antibodies for solid tumors that block disease pathways and activate immune cells. The company targets cancer patients with limited treatment options using a platform approach that integrates multiple therapeutic mechanisms into single molecules.

BiotechHealthtechMedical Devicesin /aakha-biologics

Founders & leadership

HB
Hemanta BaruahFounder & CEO
EA
Errik AndersonDirector
CP
Christopher PachecoDirector
GR
George Robert Mabry IIIDirector

Investors · 1

82VSBoston

Reported raises · per SEC filings

Form D private placements
▶$750KraisedJul 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher PachecoDirector
  • Hemanta BaruahExecutive Officer, Director
  • Errik AndersonDirector
  • George Robert Mabry IIIDirector
Offering amount
$5M
Amount sold
$750K
Proceeds to insiders
$100K
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news